Details.
Evidence-based plasma exchange with albumin replacement for Alzheimer's disease, reported to slow cognitive decline by 52 to 71%.
at Kiprov Dobri D MD · San Francisco
Evidence-based plasma exchange with albumin replacement for Alzheimer's disease, reported to slow cognitive decline by 52 to 71%.
Get the app to book and see what else is on nearby.